Sleep/wake problems in Parkinson's disease: pathophysiology and clinicopathologic correlations
1University of Texas Health Science Center-Houston, 6410 Fannin, Ste 1014, Houston, TX, 77030, USA, william.ondo@uth.tmc.edu.
Summary
Sleep disturbances are common in Parkinson's disease (PD), affecting most patients. This review explores the causes of these varied sleep issues, including dopaminergic and non-dopaminergic pathology, and PD treatments.
Area of Science:
- Neurology
- Sleep Medicine
- Neuroscience
Background:
- James Parkinson first described sleep disturbances in "shaking palsy" (now Parkinson's disease).
- The majority of Parkinson's disease patients experience significant sleep disturbances.
- These issues range from insomnia and fragmented sleep to parasomnias and daytime sleepiness.
Purpose of the Study:
- To explore the pathophysiology of diverse sleep disorders in Parkinson's disease.
- To discuss the multifactorial etiologies behind these sleep disturbances.
- To examine the roles of dopaminergic dysfunction, non-dopaminergic pathology, and treatments in PD-related sleep issues.
Main Methods:
- Literature review of existing studies on Parkinson's disease and sleep.
- Analysis of the pathophysiology of sleep disturbances in PD.
- Discussion of etiological factors contributing to sleep phenotypes.
Main Results:
- Sleep disturbances are a prevalent symptom in Parkinson's disease patients.
- The causes of these sleep disorders are often multifactorial and debated.
- Potential contributing factors include dopaminergic deficits, non-dopaminergic neurodegeneration, and therapeutic interventions.
Conclusions:
- Sleep disturbances are integral to the Parkinson's disease experience.
- Understanding the varied pathophysiology is crucial for managing PD-related sleep issues.
- Further research is needed to fully elucidate the complex interplay of factors affecting sleep in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
21
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
21
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
01:11Alterations in Muscle Tone lll
27
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
27